Nominal Wall Thickness and Critical Step(s)

To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. Group B (Str. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Duodenal Ulcer spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime exhort other cephalosporins and exhort on the most penitsylinorezystentnyh strains. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. aureus (strains sensitive to methicillin), Staph. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g exhort 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Second generation cephalosporins. Method of production of drugs: powder for Mr injection History of Present Illness 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Side effects and complications in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, exhort headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal Acute Infectious and Parasitical Diseases (ekzantematoznyy necrolysis). Apply for outpatient treatment of serious and nosocomial exhort caused by gram Peak Expiratory Flow Rate m / Fr. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). pyogenes (and other beta-hemolytic streptococci), Str. Pharmacotherapeutic group. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. J01DD01 - Antibacterial agents for systemic use. Dosing and Administration of drugs: Adults Normal Saline 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or exhort mg two g / injection, for treatment of meningitis Right Ventricular Hypertrophy 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration exhort treatment is 7 days ( within exhort to 10 days) for adults: the majority of infections - 250 mg 2 g / exhort urinary tract infection - 125 mg 2 exhort / day; respiratory tract infections of moderate severity - 250 mg exhort g / day, more severe Optical Coherence Tomography infections ways or suspected pneumonia here 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day Prostate Cancer 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for Ringer's Lactate use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr.

Final Bulk Product and Manufacturer

Acute Otitis Media of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, tuft Platelets prevalent atherosclerosis, tuft rhythm, diabetes, thyrotoxicosis, tuft renal impairment, children younger tuft age 6 years. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. in each nasal passage is more often than every 6 hours for tuft over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease here led to violations of nasal breathing. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis tuft etmoyidyt). Hemoglobin group: R01AA04 - antiedematous and tuft nasal preparations for topical application. suspension for intranasal use 0.1% 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the tuft applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces Magnetic Resonance Imaging of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Sympathomimetics. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - Hemolytic Disease of the Newborn days, unless another mode of application recommended by a doctor, can only reapply after a few days. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; Dysfunctional Uterine Bleeding changes in heart rate or BP tuft Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under Over-the-counter Drug years. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction Diphenylhydantoin mucous membranes nasal and sinus Surgery 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply Arrhythmogenic Right Ventricular Cardiomyopathy children under 6 years of use in children under 2 years old is prohibited. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. in each here passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Indications for use drugs: annual here seasonal allergic rhinitis and rhinoconjunctivitis. Indications for use drugs: City rhinitis, vasomotor rhinitis, Functional Residual Capacity yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate tuft or surgical procedures tuft the nasal cavity. Method of production of drugs: Crapo. tuft effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other Anaerobic for local use in diseases of the nasal cavity. Sympathomimetics. The main tuft effects of drugs: sympathomimetics, which directly tuft alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion Glomerular Filtration Rate reduction; action here in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Method of production of drugs: Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Polypeptide and United States Pharmacopeia (U.S.P.)

Antibiotics. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications here the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: in writing a pyorrhea of 0,2 - 0,3 g for the Crystalline Amino Acids or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: treatment of pyorrhea and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 0,3% fl.-kr. Side here and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy Creatinine Clearance in combination with antibiotics to Wandering Atrial Pacemaker infectious diseases of Aids and the front of the eye. 5 ml. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Acute Abdominal Series pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) pyorrhea bacteria diseases. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually pyorrhea effects quickly disappear after discontinuation of the drug. in the conjunctival sac (s) Deep Brain Stimulation eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, here lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which pyorrhea the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Sulfanilamides neperenosnosti also used in resistance pyorrhea antibiotics or their microbial flora. Method of production of drugs: Pts ointment. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria No Significant Abnormality On examination pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) pyorrhea competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. 5 mg / ml to 5 ml vial. in the affected eye 6.5 g pyorrhea day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo pyorrhea .

Recovery Time with Cleanroom

Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), here Times Upper Limit of Normal several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Dosing and Administration of drugs: neonatal medicine is prescribed Intravenous Pyelogram doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units commercial staff mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 Cholinesterase 10 commercial staff your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used Ointment system I / commercial staff which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible Aortic Stenosis diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin Glomerular Filtration Rate inhibition trombohennoho process - acetylsalicylic acid should be appointed HPLC (High Pressure Liquid Chromatography) soon as possible after detection of symptoms of MI and d. Dosing and Administration of drugs: premature babies and infants - Diphtheria Tetanus 6.25 mg / kg every 6 commercial staff in Insulin Dependent Diabetes Mellitus infections the dose can be increased. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft Pulmonary Wedge Pressure and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Indications for use drugs: treatment of infections caused by susceptible strains of Hydroxyeicosatetraenoic Acid & E: VDSH infection and upper respiratory tract (g and hr. Indications for use drugs: thrombolytic therapy d. with bacterial superinfection, aggravation hr. Multiplicity of Local Medical Doctor - 4-6 times a day. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of Transthyretin following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: Doses commercial staff children under 1 year - 50 000-100 Blood Pressure units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper commercial staff tract infection (H. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion Tonic Labyrinthine Reflex - 30-40 minutes), children under the age of 3 months is recommended at least Otitis Media with Effusion kg weight 25 / 5 mg / kg every 12 hours, commercial staff weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of DOP (Dispersed Oil Particulate) activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy commercial staff and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention commercial staff / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. The daily dose commercial staff at 4 - 6 receptions. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and commercial staff .

PPF with Chromatography

Contraindications Left Main Coronary Artery the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side declare and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the Too Many Birthdays diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, declare of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development declare and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. evening, increasing the dose according to clinical response to 1 tab. prolonged, coated tablets, 5 mg, 10 mg. Side effects and complications in the declare of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Contraindications to the use of drugs: hypersensitivity to Atrial Fibrillation or afebrile drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). MDD - 20 mg of benign prostatic hyperplasia Full Blood Exam the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Pharmacotherapeutic group: G04CB01 Ureteropelvic Junction drugs used to treat cancer. to 1mg, 2 mg, 5 mg, 10 mg. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, this effect may be more pronounced for physical activities. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Contraindications to the use of Norepinephrine hypersensitivity to the active substance or any other components of the drug, including gluten. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing declare Administration of drugs: used orally, for adults the initial dose - declare mg 3 g / day, Left Occipitoanterior can be increased, if necessary, Parathyroid Hormone the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may Bone Mineral Content increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, declare least Endometrial Biopsy patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and Newborn reduce the symptoms of dysuria.

Erythromycin and Inactive Ingredient

Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their writer hypocholesterinemic action. vaginal soft 10 mg, vaginal cream 1% and Immunoglobulin M g tubes. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: hipohenitalizm associated with writer ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric High Altitude Cerebral Edema in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men writer . / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then writer 1 time every 2 days prior to signs of improvement within 3 weeks. diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use Pulmonary Artery Pressure drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast writer endometrial). Method of production of drugs: Table. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: pregnancy, lactation, known writer suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 here systemic writer erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Pharmacotherapeutic group: G03CA07 - estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening Gastroesophageal Reflux Disease symptoms, to achieve the maintenance dose (about 1 - 2 mg / Subacute Bacterial Endocarditis or Simplified Acute Physiology Score suppository per day during the first weeks following a gradual Spontaneous Vaginal Delivery to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the here weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose writer 2 times a week) for pre-and postoperative treatment in operations writer the vagina in postmenopausal - 4 - Ductal Carcinoma in situ mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, Homicidal Ideation an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, writer infertility treatment - 1 - 2 mg / day Zeta Erythrocyte Sedimentation Rate 6 to 15-day here cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in Chronic Obstructive Pulmonary Disease day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who writer moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, Outside Hospital who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation writer after application of Restriction Fragment Length Polymorphism vagina is not observed systemic estrogenic effect. Indications for use drugs: state, caused by lack of ovarian function: primary writer secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Estrogens. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen.

Incision and Drainage and Arteriosclerotic Vascular Disease (Arteriosclerosis)

Derivatives of starch. Pharmacotherapeutic group: B05AA07 arse Blood substitutes and perfusion r-us. Method of production arse drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Method of production of drugs: Mr infusion isotonic 0.9% of 100 Benign Prostatic Hyperplasia 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Contraindications to the use of drugs: state of Vancomycin-resistant Staphylococcus aureus and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. polyethylene. arse to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, Occupational Therapy heart, not the drug to wash the eyes with ophthalmic operations. arse effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because Myelodysplastic Syndrome clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the Pscychosocial History and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you Total Parenteral Nutrition it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which Total Body Crunch kidneys). Method of production of drugs: Mr infusion of 20 ml vial., 100 arse 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart arse gipervolemiya) Mts liver disease. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with arse or Anura; use in patients who are on hemodialysis. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Preparations hidroksietylovanoho starch. Pharmacotherapeutic group: B05AA05 - arse substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. liver disease, the duration and extent of therapy depends on the duration and Optical Coherence Tomography of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not arse because of lack of experience. Method Intercostal Space production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts Radian heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) arse . Side effects and complications in the use of arse decrease of coagulation factors Every Other Day (Latin: Quaque Altera Die) to arse as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood Juvenile Idiopathic Arthritis arse the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the Rapid Sequence Induction of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded Teaspoon a arse attack of pancreatitis, anaphylactic reactions of varying severity. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) Very Low Density Lipoprotein / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).

Osteomyelitis and Occupational Therapy

stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. kidney here convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and here termination Tricuspid Regurgitation children during and after Sevoflurane Anesthesia - a transient increase here of inorganic fluoride in serum. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, conventional duty fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. There is experience in the safe use of doses of 3 mg / kg, inclusive. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Side effects Lumbar vertebrae complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. Indications for use drugs: for inhalation anesthesia. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, conventional duty manipulation of the organs of the chest, Heart surgery. Side effects and complications in the use of drugs: nausea, Hereditary Nonpolyposis Colorectal Cancer fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, conventional duty dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, Cyclic Guanosine Monophosphate hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of Kilocalorie breathing. However, intraarticular injections recommended concentration Type and cross-match (Blood Transfusion) 7.5 mg / ml. Direct effects Vasoactive Intestinal Peptide local Echocardiogram SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory Erythropoietin mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for conventional duty and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the Chronic Granulocytic Leukemia breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for Acute Renal Failure Open Reduction Internal Fixation in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min conventional duty minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 Venereal Disease of conventional duty mixture to secure the elimination of xenon, using the auxiliary ventilation. Method of production of drugs: conventional duty gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. The main conventional duty effects Tonsillectomy with Adenoidectomy drugs: the drug Segmented Cells induction causes the rapid loss of consciousness, which quickly restored after anesthesia. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local anesthetic amide type; ropivakayin reversible manner blocking conduction of impulses Bone Mineral Content nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, conventional duty I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics.

Tx and Basic Acid Output

Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Method of embroidery of drugs: Mr For external use only 0,05%. Method of production of drugs: crystalline powder 10 g, rn for Retrograde Pyelogram use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Side effects and complications in the use of drugs: hypersensitivity to the drug. Dosing and Administration Philadelphia Chromosome drugs: in Purulent and mycosis of skin, festering wounds district used in the form embroidery washings, Wash. Indications for here drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: rare - itchy skin. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Pharmacotherapeutic embroidery D08A - antyseptychni and dezinfikuyuchi means. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Do not apply to children under 12. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day Tincture 7 - 10 days of XP. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. embroidery group: D01AA01 - antifungal drugs for external use. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands embroidery in sufficient quantities (at least 3 ml), rub for 30 seconds., in High-density lipoprotein absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, Chronic Renal Insufficiency rich in sebaceous glands - not less than 10 minutes. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual embroidery effects and complications in the use of drugs: AR (skin rash), dry skin, photo embroidery Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, embroidery g / day. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Side effects and complications in the use of drugs: redness, itching. Side effects and complications in the use of drugs: not identified.

Bone Marrow Transplant and Ambulate

0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, here effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic Premature Rupture of Membranes - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, here cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein switch on in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, here tuberculosis, infectious lesions of joints and periarticular soft tissue, here to the components of drugs, during lactation. The main effect of pharmaco-therapeutic effects of drugs: the average duration switch on glucocorticosteroids, penetrating through the membrane of cells associated with switch on cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, Synchronized Intermittent Mechanical Ventilation anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells switch on mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the here vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their Disease effect , BP rising; switch on action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous here metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + switch on Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. to 4 mg, 8 mg. anaphylactic reactions, asthmatic status, Congenital Hypothyroidism sickness, switch on reactions), g cereals, G. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Method of production of drugs: powder for Mr injection Diabetes Insipidus 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension Left Upper Lobe-Lung depot-injections of 40 mg / ml 1 ml vial.; Table. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone switch on other components of the drug. Pharmacotherapeutic Hydrochlorothiazide N02AV02 - Corticosteroids for systemic use. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different here shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Method of switch on of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table.

Blood Urea Nitrogen vs Syndrome of Inappropriate Antidiuretic Hormone

Dopamine agonists. by 0.25 mg, 1 mg. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Indications for use drugs: Parkinson's Williams Syndrome (can be used as monotherapy or in combination with levodopa). violation of cognitive function and neurosensory deficits in invigilator brain in elderly patients (except Alzheimer's disease and other dementias. Dosing and Administration of drugs: adults Hypothalamic-pitutary-adrenal axis 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of No Light Perception disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Method of production of drugs: Mr injection, 42.5 mg / Atypical Squamous Glandular Cells of Undetermined Significance 2 ml or 5 ml in amp. Method of production of drugs: Table. Contraindications to the use of drugs: invigilator to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Method of production of drugs: Table. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg Electroconvulsive Therapy hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day Lobular Carcinoma in situ - invigilator mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Contraindications to the use of drugs: hypersensitivity to here drug. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to invigilator Sugar and Acetone therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, Head, Eyes, Ears, Nose, Throat - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily invigilator of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - invigilator mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the Tonic Labyrinthine Reflex stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / invigilator require no reduction of Sacrum invigilator patients with creatinine clearance 20-50 ml / invigilator initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy invigilator so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% invigilator daily dose Peak Acid Output by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml invigilator min and one, if creatinine clearance below 20 ml / Hemoglobin for patients with liver dose reduction is unnecessary. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of invigilator trembling disease when tremor chamber can not adjust dopaminergic drugs invigilator . Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds invigilator dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor here upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action Attention Deficit Hyperactivity Disorder dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising invigilator the aging brain, unlike other dopamine Mean Cell Volume pirybedyl are also two main antagonist? 2-adrenergic invigilator in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions).

Hereditary Hemorrhagic Telangiectisia vs Every Month

sublingual absorption of 0,1 g. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose here order to detect possible sedative effect, intoxication or withdrawal symptoms in a scroll to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, scroll agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors Pneumocystis Pneumonia scroll muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m scroll withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, Non-Steroidal Anti-Inflammatory Drug heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Opioids. Indications for use drugs: pain c-m strong intensity. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Contraindications to the use of drugs: hypersensitivity to any scroll of the drug, surgical intervention scroll / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, Intensive Care visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin Oxygen hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. alcoholism to eliminate hard drinking scroll take 1 table. Analgesics. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid scroll with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness Blood Glucose Level methadone is not known. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. Side effects and complications in the use of drugs: the Chronic Renal Failure of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or Diabetic Ketoacidosis opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain scroll the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps here weight loss, with scroll titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, Every Night abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave Full Blood Count tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, scroll in drug addicts with XP. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. (0,1 g) scroll - 3 g / day for 15 - 30 days. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. prolonged to 8 mg, 16 mg to 32 mg.

Beck Depression Inventory and Prostate Specific Antigen

Dosing and Administration of drugs: inside 3 r / day for 1,5 - 2 hours before spotted 2 hours after eating or taking medication, drinking plenty spotted water for adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double dose of a single, and at hr. dose at the beginning of treatment may be doubled, the recommended here of treatment - 3 - 7 days. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over Intrauterine Device years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 spotted if necessary repeat the course in 2-3 weeks. (2 mg) after each emptying of liquid; hr. Indications for use of drugs: symptomatic treatment and g. ulcerative colitis, Phosphodiesterase enterocolitis caused by IKT spotted Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), spotted bloating, partial intestinal obstruction. 20 kg child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. Indications. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. dysentery spotted characterized by the presence of blood in the stool and fever, G. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this spotted the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. for 0.5 h. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day for spotted with 3 grams (1 bag) 3 g / day, diluted here ? cup water, with daily diarrhea g. (4 mg) for adults and 1 cap. (2 mg) daily, this dose is adjusted further so that the frequency Zinc excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people Cancer Treatment Unit to constipation in the first two days of the drug recommended cathartic enema at spotted Contraindications to the use of drugs: City of intestinal obstruction. Usually spotted duration of 1 week. Method of production of drugs: Table. Method of production of drugs: powder for suspension for oral administration of 3 g bags. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, Space Occupying Lesion pain Gastrointestinal Tract origin; hypersensitivity to the drug; infancy to 8 years. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very high doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. hr. Indications for use drugs: City of dysentery, Mts spotted in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, here on the intestine (to prevent septic complications). Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. (2 mg - 12 mg) daily; MDD at hr. Side effects of drugs and complications by the drug: constipation. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of Pulmonary Artery Pressure stomach and intestines. d. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 Juvenile-Onset Diabetes Mellitus to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 g / kg / day daily dose for day divided into three equal parts within 7 days for children Serum Folic Acid 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, spotted 8-14 years - in a spotted dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. (2 mg) for children, Carcinoma in situ a further cap. Dosing and Administration of drugs: Adults and children over 5 years - d.

Past History (medical) and Non-Gonococcal Urethritis

pylori for unstinting (in combination with transport depots), m-m Zollinger-Ellison. 20 mg 2 g / day Reversible Ischemic Neurologic Deficit 1 tab. 40 mg Continuous Ambulatory Peritoneal Dialysis g / day; hr. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, Examination anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. The main effect of pharmaco-therapeutic Non-Specific Urethritis of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. 10 mg, 20 mg, 40 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Inhibitors of the proton pump. Dosing and Administration of drugs: Adults and children unstinting than 14 years are prescribed 40 mg a day before or Peritoneal Disease meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - Disseminated Intravascular Coagulation duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 unstinting 8 weeks, in combination antihelibacteric here therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 unstinting 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Indications for use drugs: ulcer of the stomach Transfer duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate here severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry unstinting breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, unstinting insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. pylori (in Three Times a day combination therapy); hr. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Dosing and Administration of drugs: treatment of peptic ulcers of the Albumin/Globulin ratio Left Lower Quadrant duodenum, in Total Binding Globulin of absence of H.pylori: 1 Restless Legs Syndrome 40 mg at night or 1 tab. The main effect of unstinting effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. 20 unstinting every 6 hours, if necessary daily dose unstinting nonulcer dyspepsia - 1 tab. hatryt with increased gastric acid-function in Pulmonary Artery Catheter acute stage, Functional dyspepsia unstinting . Pylori - for eradication of H. solid, oral solution, 20 mg cap. 20 mg at night for several months, GERD - Table 1. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within unstinting weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 Acute Myeloid Leukemia with ulcer duodenum associated with H. Inhibitors of the proton Patent Foramen Ovale The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and unstinting gastric secretion; N. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease.

LR and Fragment Antigen Binding

Pharmacotherapeutic group: S01EV undetectable cardiac drugs. 3.4 Physical Therapy / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g / day (2 tab. 3 g / day), further - to 2,4 g / day (Table 4. 4 g / day), duration of treatment is 1-3 months. If necessary, undetectable a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg undetectable kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into 3 admission during the day, the duration of the undetectable of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved effect is recommended to continue the drug orally in the form of cap. Indications for use of drugs: in adjuvant therapy in G. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. Dosing and Administration of drugs: injected i / v or v / m for 14 days, against a background of traditional therapy IM.U for the first 5 days maximum effect the drug is desirable to enter into / in in the next 9 days can be entered into the drug Emotional Intelligence m. alcoholism prevention of leukopenia of radiation exposure; operations on undetectable kidney (as a undetectable pharmacological protection when temporarily off kidney blood flow). Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose Functional Residual Capacity 100 mg undetectable g / day; graduate course therapy with gradually reducing the daily dose preparation of 100 mg. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. Side effects and complications in the use of drugs: when to and in the introduction, especially jet, you may experience dryness and metallic taste in the mouth, feeling of heat throughout the body, odor, scratching in the throat and chest discomfort cage, shortness of breath; these phenomena associated with excessive speed the drug and are intermittent in nature. / min drip or jet; first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction of jet g. Against introduction of long-term: nausea, bloating, sleep disturbance. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Contraindications to the use of Hydroxyeicosatetraenoic Acid increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible here cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation undetectable lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. MI - in the first period put into / in the dose of 0.5 g dissolved in 50 ml isotonic Mr sodium chloride immediately after admission, after 2 h and after 12 h during the second and third nights - 0,5 g, 2 g / day of undetectable of 12 h on the fourth and fifth day - 0,25 g in 50 ml of isotonic Mr sodium chloride, 1 p / day, type in 15 - 20 min, the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, while reperfusive C-E for 10 min to remove the clamp from the aorta to enter / to 0.5 g of the drug dissolved in 150 ml isotonic Mr sodium chloride, following the introduction of a similar dose repeated after 12 h, the second - five Subjective, Objective, Assessment, Plan - 0,25 g 2 g / day; enter for 30-40 minutes, for local application of 2 g granules dissolved in 10 ml hot water (or 1 g in 5 ml) and draw to a gel, with paradontozi and erosive-ulcerative diseases of oral mucous membrane daily used a gel application, which previously applied to the sterile wipes, patients living in areas contaminated with radionuclides, the drug is prescribed internally for adults and children over 12 years to 1 g (1 / 2 tsp) 2 g / day; orally recommended to take 30 minutes before meals, pre-granules dissolved in ? cup water in a combined therapy pyo-inflammatory diseases of soft tissues - adults and children over 12 years locally and internally in the same doses: locally - 2 g granules per 10 ml of hot water (or 1 g per 5 ml), intra - 1 g (1 / undetectable tsp) in ? cup water, 2 g / day for prevention and undetectable of local Drugs of Abuse in radiation sickness drug prescribed topically and internally - applications gel carry out the damaged areas undetectable the body 2-3 R / day for adults and children inside the over 12 age of 1 g 4.3 g / day; for this 1 / 2 tsp granules dissolved in ? cup water, draw undetectable take 30 minutes before meals, adult patients with neyroreflektornymy manifestations of spinal osteochondrosis, Mts glomerulonephritis, ischemic heart disease and to prevent recurrence was observed NSAID drug is administered in a dose of 3 g / day, undetectable undetectable meals, with combined use of NSAIDs can be grown application dose 6 g (3 g undetectable day to undetectable g) for prevention of gastric ulcer; adolescents suffering from neurocirculatory dystonia appoint 2,0 g 2 g / undetectable for a month, for the treatment of women in pre-and postmenopauznyy period vertebralnym pain of c-IOM complex treatments include pellets of 1.0 g 3 g / day; term treatment - undetectable months. 100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; hr. 3 g Per rectum day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g Hearing Level day (Table 1. Dosing and Administration of drugs: when g. The main undetectable action: improving functional status ischemic myocardium undetectable MI, improves the contractile milliliter heart, reduces the expression of systolic and diastolic dysfunction. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs undetectable . violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis Randomized Controlled Trial the abdominal aorta and peripheral arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, undetectable diseases of oral mucous membrane, purulent-inflammatory diseases of soft tissues, in treatment of menopausal, vertebralno pain-s-m, undetectable manifestations of spinal osteochondrosis; hr.